Alcon Associate Being Monitored for Signs and Symptoms of Ebola Virus
Oct 14, 2014
Alcon Associate Being Monitored for Potential
Signs and Symptoms of Ebola Virus
Fort Worth, Texas, October 13, 2014 -- An Alcon associate was admitted to Texas Health Presbyterian Hospital on Sunday, October 12, and is being monitored for potential signs and symptoms of the Ebola virus, based on the Centers for Disease Control and Prevention (CDC) protocol. This measure was taken due to the fact that the associate was in contact with the Texas Health Presbyterian health care worker who has recently tested positive for the virus. The Alcon associate has not shown any signs or symptoms of the Ebola virus.
After consultation with the Texas Department of Health, we are confident that there is no risk for Alcon associates. We are working closely with the Centers for Disease Control and Prevention (CDC) and the Texas Department of Health to ensure we are following proper public health measures. We are taking all necessary measures, as directed by the CDC and according to our own internal protocols.
Our thoughts are with our co-worker and their friends and family. We are not releasing the name of the associate for reasons of privacy.
About Alcon: Alcon, the global leader in eye care, provides innovative products that enhance quality of life by helping people worldwide see better. The three Alcon businesses - Surgical, Pharmaceutical and Vision Care - offer the widest spectrum of eye care products in the world. Alcon is the second largest division of the Novartis Group, with pro-forma sales of USD 10.5 billion in 2013. Headquartered in Fort Worth, Texas, USA, Alcon has more than 25,000 employees worldwide, operations in 75 countries and products available in 180 markets. For more information, visit www.alcon.com.
Media Contact: Elizabeth Harness Murphy Alcon Global Communications +1 (585) 435 - 7379 (mobile) [email protected]